Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial

BACKGROUND: We conducted a randomized controlled trial to investigate whether an additional platelet inhibition with tirofiban would reduce the extent of myocardial damage and prevent periprocedural myonecrosis in patients with Non-ST-elevation acute coronary syndrome (NSTE-ACS) with a high residual...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Wonjae, Suh, Jung-Won, Park, Jin Joo, Yoon, Chang-Hwan, Cho, Young-Seok, Youn, Tae-Jin, Chae, In-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198526/
https://www.ncbi.nlm.nih.gov/pubmed/30348101
http://dx.doi.org/10.1186/s12872-018-0938-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198526/
https://www.ncbi.nlm.nih.gov/pubmed/30348101
http://dx.doi.org/10.1186/s12872-018-0938-6

Ejemplares similares